Amicus Therapeutics
FOLD
#3365
Rank
A$6.29 B
Marketcap
A$20.07
Share price
0.03%
Change (1 day)
30.58%
Change (1 year)

EPS for Amicus Therapeutics (FOLD)

EPS in 2025 (TTM): A-$0.17

According to Amicus Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$0.15. In 2014 the company made an earnings per share (EPS) of A-$1.30.

EPS history for Amicus Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.17
2014A-$1.30
2012A-$1.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
A$4.93-3,294.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
A$15.42-10,090.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.29-3,525.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
A-$0.27 72.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.70 354.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$3.82-2,572.73%๐Ÿ‡บ๐Ÿ‡ธ USA